We are live on
!
Find out more
OAC
OMERS Administration Corp Portfolio holdings
AUM
$16.7B
1-Year Est. Return
35.96%
This Fund
S&P 500
This Quarter
Est. Return
+23.08%
1 Year Est. Return
+35.96%
3 Year Est. Return
+106.41%
5 Year Est. Return
+114.67%
10 Year Est. Return
+344.51%
AUM
$16.7B
AUM Growth
+$1.16B
(+7.5%)
Cap. Flow
-$545M
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
30.99%
Holding
1,188
New
92
Increased
466
Reduced
166
Closed
282
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$318M |
| 2 |
Royal Bank of Canada
RY
|
+$260M |
| 3 |
Meta Platforms (Facebook)
META
|
+$240M |
| 4 |
Citigroup
C
|
+$220M |
| 5 |
Micron Technology
MU
|
+$194M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$463M |
| 2 |
Apple
AAPL
|
+$266M |
| 3 |
Prologis
PLD
|
+$192M |
| 4 |
NVIDIA
NVDA
|
+$168M |
| 5 |
Coca-Cola
KO
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.31% |
| 2 | Financials | 22.79% |
| 3 | Industrials | 9.5% |
| 4 | Communication Services | 8.24% |
| 5 | Consumer Discretionary | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Relmada Therapeutics
RLMD
$463M
| – | – |
-41,600
| Closed | -$290K |
|
1102
Rapid Micro Biosystems
RPID
$63.7M
| – | – |
-15,900
| Closed | -$36.1K |
|
1103
Revvity
RVTY
$14.2B
| – | – |
-4,433
| Closed | -$388K |
|
1104
SAB Biotherapeutics
SABS
$338M
| – | – |
-29,700
| Closed | -$114K |
|
1105
Sharplink Inc
SBET
$1.87B
| – | – |
-23,400
| Closed | -$151K |
|
1106
Scholastic
SCHL
$691M
| – | – |
-29,800
| Closed | -$1.16M |
|
1107
SEI Investments
SEIC
$13.2B
| – | – |
-4,666
| Closed | -$366K |
|
1108
Senseonics Holdings Inc
SENS
$496M
| – | – |
-31,000
| Closed | -$206K |
|
1109
SES AI
SES
$199M
| – | – |
-95,900
| Closed | -$92.3K |
|
1110
Sagimet Biosciences
SGMT
$683M
| – | – |
-41,100
| Closed | -$215K |
|
1111
Sidus Space
SIDU
$213M
| – | – |
-30,000
| Closed | -$69.6K |
|
1112
J.M. Smucker
SJM
$13.2B
| – | – |
-3,956
| Closed | -$382K |
|
1113
Soluna Holdings
SLNH
$311M
| – | – |
-107,100
| Closed | -$75.7K |
|
1114
SmartRent
SMRT
$247M
| – | – |
-127,800
| Closed | -$192K |
|
1115
Snap
SNAP
$9.18B
| – | – |
-219,761
| Closed | -$1.01M |
|
1116
Smart Sand
SND
$227M
| – | – |
-37,300
| Closed | -$191K |
|
1117
Virgin Galactic
SPCE
$478M
| – | – |
-82,100
| Closed | -$200K |
|
1118
Spero Therapeutics
SPRO
$70.5M
| – | – |
-39,400
| Closed | -$92.2K |
|
1119
Surf Air Mobility
SRFM
$79.8M
| – | – |
-78,600
| Closed | -$90.4K |
|
|
SRG
1120
Seritage Growth Properties
SRG
$115M
| – | – |
-24,200
| Closed | -$68K |
|
1121
Stoneridge
SRI
$209M
| – | – |
-22,400
| Closed | -$108K |
|
|
TRON
1122
Tron Inc
TRON
$745M
| – | – |
-49,400
| Closed | -$112K |
|
|
STKL
1123
DELISTED
SunOpta
STKL
| – | – |
-489,500
| Closed | -$3.17M |
|
1124
Sutro Biopharma
STRO
$323M
| – | – |
-8,700
| Closed | -$217K |
|
1125
Shattuck Labs
STTK
$674M
| – | – |
-33,300
| Closed | -$214K |
|
Similar funds
VRS
EH
RFC
FCAS
NMO
AT
TI
MFG
OMERS Administration Corp's Q2 2026 Portfolio in Review
As of Q2 2026, OMERS Administration Corp held 1,188 positions worth $16.7B, up 7.5% from $15.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
OMERS Administration Corp withdrew a net $545M in Q2 2026, closing 282 positions and reducing 166 holdings. Its most notable exit was AstraZeneca, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
Against the trend, OMERS Administration Corp opened a new position in Brookfield Asset Management worth $30.3M.
- OMERS Administration Corp's largest Q2 2026 buy was Brookfield Asset Management: 675,600 shares worth $30.3M.
- OMERS Administration Corp added most to Canadian Natural Resources in Q2 2026, an estimated $318M increase.
- OMERS Administration Corp's biggest Q2 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $463M.
- OMERS Administration Corp fully exited AstraZeneca in Q2 2026, selling an estimated $160M.
- OMERS Administration Corp's ten largest holdings make up 31% of its $16.7B portfolio in Q2 2026.
- OMERS Administration Corp opened 92 new positions and closed 282 in Q2 2026.
- OMERS Administration Corp's portfolio value rose 7.5% quarter-over-quarter to $16.7B.
Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.